Anteris Technologies Global Corp. - Common Stock (NQ:AVR)

5.900 -0.250 (-4.07%)

Streaming Delayed Price Updated: 10:30 AM EST, Feb 3, 2026 Add to My Watchlist

Price and Volume

Volume	168,969
Open	6.150
Bid (Size)	5.880 (300)
Ask (Size)	5.910 (400)
Prev. Close	6.150
Today's Range	5.830 - 6.150
52wk Range	2.340 - 8.790
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

January 22, 2026

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

January 22, 2026

From Anteris Technologies Global Corp.

Via GlobeNewswire

Performance

YTD	+19.9%	+19.9%
1 Month	+23.4%	+23.4%
3 Month	+35.6%	+35.6%
6 Month	+72.0%	+72.0%
1 Year	-4.8%	-4.8%

More News

The trading volume of these stocks is deviating from the norm in today's session. ↗

January 22, 2026

Via Chartmill

Why Did AVR Stock Surge Pre-Market Today? ↗

January 21, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today ↗

January 21, 2026

Via Stocktwits

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

January 20, 2026

From Anteris Technologies Global Corp.

Via GlobeNewswire

Top movers in Tuesday's after hours session ↗

January 20, 2026

Via Chartmill

Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic

January 20, 2026

From Anteris Technologies Global Corp.

Via GlobeNewswire

Wondering what's happening in today's after-hours session? ↗

December 31, 2025

Via Chartmill

Top movers in Thursday's after hours session ↗

November 27, 2025

Via Chartmill

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

November 17, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Announces Results for the Third Quarter of 2025

November 12, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

November 03, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year

October 28, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 28, 2025

Via Benzinga

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

October 27, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

October 27, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 20, 2025

Via Benzinga

Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

October 15, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

September 19, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗

September 18, 2025

Via Benzinga

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

September 11, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

September 04, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Anteris Announces Results for the Second Quarter of 2025

August 11, 2025

From Anteris Technologies Global Corp.

Via GlobeNewswire

Frequently Asked Questions

Is Anteris Technologies Global Corp. - Common Stock publicly traded?

Yes, Anteris Technologies Global Corp. - Common Stock is publicly traded.

What exchange does Anteris Technologies Global Corp. - Common Stock trade on?

Anteris Technologies Global Corp. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Anteris Technologies Global Corp. - Common Stock?

The ticker symbol for Anteris Technologies Global Corp. - Common Stock is AVR on the Nasdaq Stock Market

What is the current price of Anteris Technologies Global Corp. - Common Stock?

The current price of Anteris Technologies Global Corp. - Common Stock is 5.900

When was Anteris Technologies Global Corp. - Common Stock last traded?

The last trade of Anteris Technologies Global Corp. - Common Stock was at 02/03/26 10:30 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.